Insulin secretagogue
This page covers all Insulin secretagogue drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ATP-sensitive potassium channels.
Targets
ATP-sensitive potassium channels
Phase 3 pipeline (1)
- insulin secretagogue · Sanofi · Diabetes
Stimulates the release of insulin from the pancreas.
Phase 2 pipeline (1)
- C-peptide · Creative Peptides Sweden Inc. · Diabetes
C-peptide is a naturally occurring peptide hormone that regulates insulin secretion.